{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T03:37:32Z","timestamp":1785728252848,"version":"3.56.0"},"reference-count":27,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T00:00:00Z","timestamp":1769472000000},"content-version":"am","delay-in-days":332,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","jamda.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Medical Directors Association"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.jamda.2024.105459","type":"journal-article","created":{"date-parts":[[2025,1,27]],"date-time":"2025-01-27T09:48:36Z","timestamp":1737971316000},"page":"105459","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Medication Use in People Aged 90\u00a0Years and Older: A Nationwide Study"],"prefix":"10.1016","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3685-8407","authenticated-orcid":false,"given":"Lukshe","family":"Kanagaratnam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Semenzato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edouard-Pierre","family":"Baudouin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo\u00ebl","family":"Ankri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alain","family":"Weill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmoud","family":"Zureik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jamda.2024.105459_bib2","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.818875","article-title":"Medication use and costs among older adults aged 90 years and older in Italy","volume":"13","author":"Zazzara","year":"2022","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.jamda.2024.105459_bib3","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1517\/14740338.2013.827660","article-title":"Clinical consequences of polypharmacy in elderly","volume":"13","author":"Maher","year":"2014","journal-title":"Expert Opin Drug Saf"},{"key":"10.1016\/j.jamda.2024.105459_bib4","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.archger.2016.06.002","article-title":"Health, frailty and disability after ninety: results of an observational study in France","volume":"66","author":"Herr","year":"2016","journal-title":"Arch Gerontol Geriatr"},{"key":"10.1016\/j.jamda.2024.105459_bib5","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1111\/jgs.14317","article-title":"Prevalence of frailty and factors associated with frailty in individuals aged 90 and older: the 90+ study","volume":"64","author":"Lee","year":"2016","journal-title":"J\u00a0Am Geriatr Soc"},{"key":"10.1016\/j.jamda.2024.105459_bib6","doi-asserted-by":"crossref","DOI":"10.1093\/ageing\/afab282","article-title":"Clinical trials in older people","volume":"51","author":"Pitkala","year":"2022","journal-title":"Age Ageing"},{"key":"10.1016\/j.jamda.2024.105459_bib8","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1093\/ageing\/afr144","article-title":"Drug use in centenarians compared with nonagenarians and octogenarians in Sweden: a nationwide register-based study","volume":"41","author":"Wastesson","year":"2012","journal-title":"Age Ageing"},{"key":"10.1016\/j.jamda.2024.105459_bib9","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1093\/ageing\/afw141","article-title":"Drug use in persons with and without Alzheimer\u2019s disease aged 90 years or more","volume":"45","author":"Taipale","year":"2016","journal-title":"Age Ageing"},{"key":"10.1016\/j.jamda.2024.105459_bib10","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1111\/ggi.13880","article-title":"Drug prescription patterns and factors associated with polypharmacy in >1 million older adults in Tokyo","volume":"20","author":"Ishizaki","year":"2020","journal-title":"Geriatr Gerontol Int"},{"key":"10.1016\/j.jamda.2024.105459_bib11","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1111\/bcpt.14012","article-title":"Medication use among the oldest old in the Faroe Islands-A national cross-sectional study","volume":"134","author":"Joensen","year":"2024","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"10.1016\/j.jamda.2024.105459_bib12","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.jamda.2015.08.009","article-title":"Advanced age and medication prescription: more years, less medications? A nationwide report from the Italian medicines agency","volume":"17","author":"Onder","year":"2016","journal-title":"J\u00a0Am Med Dir Assoc"},{"issue":"Suppl 4","key":"10.1016\/j.jamda.2024.105459_bib13","doi-asserted-by":"crossref","first-page":"S149","DOI":"10.1016\/j.respe.2017.05.004","article-title":"Value of a national administrative database to guide public decisions: from the syst\u00e8me national d\u2019information interr\u00e9gimes de l\u2019Assurance Maladie (SNIIRAM) to the syst\u00e8me national des donn\u00e9es de sant\u00e9 (SNDS) in France","volume":"65","author":"Tuppin","year":"2017","journal-title":"Rev Epidemiol Sante Publique"},{"key":"10.1016\/j.jamda.2024.105459_bib14","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.therap.2024.05.003","article-title":"Use of the French National Health Data System (SNDS) in pharmacoepidemiology: a systematic review in its maturation phase","volume":"79","author":"Maillard","year":"2024","journal-title":"Therapie"},{"key":"10.1016\/j.jamda.2024.105459_bib15","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/1471-2458-9-33","article-title":"Ecological association between a deprivation index and mortality in France over the period 1997 - 2001: variations with spatial scale, degree of urbanicity, age, gender and cause of death","volume":"9","author":"Rey","year":"2009","journal-title":"BMC Publ Health"},{"key":"10.1016\/j.jamda.2024.105459_bib16","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1097\/MLR.0000000000001745","article-title":"The economic burden of disease in France from the national health insurance perspective: the healthcare expenditures and conditions mapping used to prepare the french social security funding act and the public health Act","volume":"60","author":"Rachas","year":"2022","journal-title":"Med Care"},{"key":"10.1016\/j.jamda.2024.105459_bib18","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1097\/MLR.0000000000000471","article-title":"The best use of the Charlson comorbidity index with electronic health care database to predict mortality","volume":"54","author":"Bannay","year":"2016","journal-title":"Med Care"},{"key":"10.1016\/j.jamda.2024.105459_bib19","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1002\/pds.966","article-title":"Three complementary definitions of polypharmacy: methods, application and comparison of findings in a large prescription database","volume":"14","author":"Fincke","year":"2005","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.jamda.2024.105459_bib20","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1186\/s12877-017-0621-2","article-title":"What is polypharmacy? A systematic review of definitions","volume":"17","author":"Masnoon","year":"2017","journal-title":"BMC Geriatr"},{"key":"10.1016\/j.jamda.2024.105459_bib21","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1111\/ggi.13276","article-title":"Current use of antihypertensive drugs in Japanese patients with hypertension: analysis by age group","volume":"18","author":"Ishida","year":"2018","journal-title":"Geriatr Gerontol Int"},{"key":"10.1016\/j.jamda.2024.105459_bib22","doi-asserted-by":"crossref","first-page":"2867","DOI":"10.1001\/jama.2008.892","article-title":"Use of prescription and over-the-counter medications and dietary supplements among older adults in the United States","volume":"300","author":"Qato","year":"2008","journal-title":"JAMA"},{"key":"10.1016\/j.jamda.2024.105459_bib23","doi-asserted-by":"crossref","first-page":"3047","DOI":"10.1007\/s40520-023-02600-x","article-title":"Symptomatic and preventive medication use according to age and frailty in Australian and Japanese nursing homes","volume":"35","author":"Liau","year":"2023","journal-title":"Aging Clin Exp Res"},{"key":"10.1016\/j.jamda.2024.105459_bib24","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s40520-021-01945-5","article-title":"Use of statins and associated factors in nonagenarians in the Community of Madrid, Spain","volume":"34","author":"Lahoz","year":"2022","journal-title":"Aging Clin Exp Res"},{"key":"10.1016\/j.jamda.2024.105459_bib25","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1001\/jamainternmed.2020.6084","article-title":"Evaluation of time to benefit of statins for the primary prevention of cardiovascular events in adults aged 50 to 75 years: a meta-analysis","volume":"181","author":"Yourman","year":"2021","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.jamda.2024.105459_bib26","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1001\/jamainternmed.2015.0289","article-title":"Safety and benefit of discontinuing statin therapy in the setting of advanced, life-limiting illness: a randomized clinical trial","volume":"175","author":"Kutner","year":"2015","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.jamda.2024.105459_bib28","first-page":"600","article-title":"STOPPFrail (screening tool of older persons prescriptions in frail adults with limited life expectancy): consensus validation","volume":"46","author":"Lavan","year":"2017","journal-title":"Age Ageing"},{"key":"10.1016\/j.jamda.2024.105459_bib29","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1093\/ageing\/afaa029","article-title":"Use of medication among nursing home residents: a Danish drug utilisation study","volume":"49","author":"Lundby","year":"2020","journal-title":"Age Ageing"},{"key":"10.1016\/j.jamda.2024.105459_bib30","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1177\/2042098617715381","article-title":"Adverse effects of proton-pump inhibitor use in older adults: a review of the evidence","volume":"8","author":"Maes","year":"2017","journal-title":"Ther Adv Drug Saf"},{"key":"10.1016\/j.jamda.2024.105459_bib31","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s12877-019-1064-8","article-title":"Drug use differs by care level. A cross-sectional comparison between older people living at home or in a nursing home in Oslo, Norway","volume":"19","author":"Fog","year":"2019","journal-title":"BMC Geriatr"}],"container-title":["Journal of the American Medical Directors Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S152586102400882X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S152586102400882X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,6]],"date-time":"2025-03-06T21:05:48Z","timestamp":1741295148000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S152586102400882X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":27,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["S152586102400882X"],"URL":"https:\/\/doi.org\/10.1016\/j.jamda.2024.105459","relation":{},"ISSN":["1525-8610"],"issn-type":[{"value":"1525-8610","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Medication Use in People Aged 90\u00a0Years and Older: A Nationwide Study","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Medical Directors Association","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jamda.2024.105459","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Post-Acute and Long-Term Care Medical Association.","name":"copyright","label":"Copyright"}],"article-number":"105459"}}